AI assistant
LABCORP HOLDINGS INC. — Director's Dealing 2017
Feb 9, 2017
30237_dirs_2017-02-09_33c3d117-00a8-4b1f-9a91-2adab92dc385.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2017-02-07
Reporting Person: EBERTS F SAMUEL III (Chief Legal Officer, Secretary)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-07 | Restricted Stock Unit | $ | A | 890 | Acquired | Common Stock (890) | Direct | |
| 2017-02-07 | Non-qualified Stock Options | $130.60 | A | 3400 | Acquired | 2027-02-06 | Common Stock (3400) | Direct |
Footnotes
F1: Each restricted stock unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/2018.
F3: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
F4: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
F5: The option vests in three equal annual installments beginning on the date reflected in this column.